Literature DB >> 16802783

Preparation, characterization, and substrate metabolism of gold-immobilized cytochrome P450 2C9.

Peter M Gannett1, Jarod Kabulski, Felio A Perez, Zhongyuan Liu, David Lederman, Charles W Locuson, Robyn R Ayscue, Nissa M Thomsen, Timothy S Tracy.   

Abstract

The cytochrome P450 enzymes represent an important class of heme-containing enzymes. There is considerable interest in immobilizing these enzymes on a surface so that interactions between a single enzyme and other species can be studied with respect to electron transfer, homodimer or heterodimer interactions, or for construction of biological-based chips for standardizing cytochrome P450 metabolism or for high-throughput screening of pharmaceutical agents. Previous studies have generally immobilized P450 enzymes in a matrix or on a surface. Here, we have attached CYP2C9 to gold substrates such that the resulting construct maintains the ability to bind and metabolize substrates in the presence of NADPH and cytochrome P450 reductase. The activity of these chips is directly dependent upon the linkers used to attach CYP2C9 and to the presence of key molecules in the active site during enzyme attachment. A novel method to detect substrate-enzyme binding, namely, superconducting quantum interference device (SQUID) magnetometry, was used to monitor the binding of substrates. Most significantly, conditions that allow measurable CYP2C9 metabolism to occur have been developed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16802783      PMCID: PMC2556980          DOI: 10.1021/ja0608693

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  13 in total

1.  CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin.

Authors:  Tina M Bland; Robert L Haining; Timothy S Tracy; Patrick S Callery
Journal:  Biochem Pharmacol       Date:  2005-10-01       Impact factor: 5.858

2.  Protein film electrochemistry of microsomes genetically enriched in human cytochrome p450 monooxygenases.

Authors:  Nasreen Sultana; John B Schenkman; James F Rusling
Journal:  J Am Chem Soc       Date:  2005-10-05       Impact factor: 15.419

3.  CYP2C9 genotype-dependent effects on in vitro drug-drug interactions: switching of benzbromarone effect from inhibition to activation in the CYP2C9.3 variant.

Authors:  Matthew A Hummel; Charles W Locuson; Peter M Gannett; Dan A Rock; Carrie M Mosher; Allan E Rettie; Timothy S Tracy
Journal:  Mol Pharmacol       Date:  2005-06-13       Impact factor: 4.436

4.  Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor.

Authors:  Amanda J Haes; Lei Chang; William L Klein; Richard P Van Duyne
Journal:  J Am Chem Soc       Date:  2005-02-23       Impact factor: 15.419

5.  Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy.

Authors:  C R Jefcoate
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

6.  Biomaterial engineered electrodes for bioelectronics.

Authors:  V Pardo-Yissar; E Katz; I Willner; A B Kotlyar; C Sanders; H Lill
Journal:  Faraday Discuss       Date:  2000       Impact factor: 4.008

7.  Electrochemical characterisation of the human cytochrome P450 CYP2C9.

Authors:  D L Johnson; B C Lewis; D J Elliot; J O Miners; L L Martin
Journal:  Biochem Pharmacol       Date:  2005-05-15       Impact factor: 5.858

Review 8.  Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes.

Authors:  Wayne L Backes; Rusty W Kelley
Journal:  Pharmacol Ther       Date:  2003-05       Impact factor: 12.310

9.  Effector-mediated alteration of substrate orientation in cytochrome P450 2C9.

Authors:  Matthew A Hummel; Peter M Gannett; Jarrett S Aguilar; Timothy S Tracy
Journal:  Biochemistry       Date:  2004-06-08       Impact factor: 3.162

10.  Direct electrochemistry of immobilized human cytochrome P450 2E1.

Authors:  Andrea Fantuzzi; Michael Fairhead; Gianfranco Gilardi
Journal:  J Am Chem Soc       Date:  2004-04-28       Impact factor: 15.419

View more
  7 in total

1.  Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolism.

Authors:  Chris D Bostick; Katherine M Hickey; Lance A Wollenberg; Darcy R Flora; Timothy S Tracy; Peter M Gannett
Journal:  Drug Metab Dispos       Date:  2016-03-09       Impact factor: 3.922

2.  Nanoscale electron transport measurements of immobilized cytochrome P450 proteins.

Authors:  Christopher D Bostick; Darcy R Flora; Peter M Gannett; Timothy S Tracy; David Lederman
Journal:  Nanotechnology       Date:  2015-03-25       Impact factor: 3.874

3.  Electrocatalytic drug metabolism by CYP2C9 bonded to a self-assembled monolayer-modified electrode.

Authors:  Mingli Yang; Jarod L Kabulski; Lance Wollenberg; Xinqi Chen; Murali Subramanian; Timothy S Tracy; David Lederman; Peter M Gannett; Nianqiang Wu
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

4.  Measurement of electron transfer through cytochrome P450 protein on nanopillars and the effect of bound substrates.

Authors:  John E Jett; David Lederman; Lance A Wollenberg; Debin Li; Darcy R Flora; Christopher D Bostick; Timothy S Tracy; Peter M Gannett
Journal:  J Am Chem Soc       Date:  2013-03-04       Impact factor: 15.419

Review 5.  Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Authors:  Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-02       Impact factor: 4.481

6.  The use of immobilized cytochrome P4502C9 in PMMA-based plug flow bioreactors for the production of drug metabolites.

Authors:  Lance A Wollenberg; Jarod L Kabulski; Matthew J Powell; Jifeng Chen; Darcy R Flora; Timothy S Tracy; Peter M Gannett
Journal:  Appl Biochem Biotechnol       Date:  2013-10-30       Impact factor: 2.926

7.  Selective filling of nanowells in nanowell arrays fabricated using polystyrene nanosphere lithography with cytochrome P450 enzymes.

Authors:  Lance A Wollenberg; John E Jett; Yueting Wu; Darcy R Flora; Nianqiang Wu; Timothy S Tracy; Peter M Gannett
Journal:  Nanotechnology       Date:  2012-09-04       Impact factor: 3.874

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.